Abstracts

T-CELL AND HEMATOPOIETIC STEM CELL GENE THERAPIES FOR HIV CURE

Since the first reported cure of an HIV-1-infected individual over a decade ago, anti-HIV cell and gene therapies have remained a primary focus of numerous HIV cure efforts. To date, hematopoietic stem and progenitor cell (HSPC) transplantation remains the only known path to cure. Although this approach is not feasible for the vast majority of…

AN MHEALTH CHW INTERVENTION TRIAL IN AN HIV HYPERENDEMIC COMMUNITY IN RAKAI, UGANDA

Effective strategies are needed to increase engagement in HIV services in HIV hyperendemic settings. We conducted a cluster-randomized trial in a fishing community on Lake Victoria (HIV prevalence ~41%) in Rakai, Uganda to assess the impact of a community health worker intervention called “Health Scouts” which used motivational interviewing strategies, a situated Information, Motivation, and…

RANDOMIZED SWITCH TO B/F/TAF IN AFRICAN AMERICAN ADULTS WITH HIV

Black Americans have the highest rates of HIV/AIDS in the US but are under-represented in HIV medical research. The single-tablet regimen bictegravir, emtricitabine, tenofovir alafenamide (B/F/TAF) is a guidelines-recommended treatment for HIV. We evaluated the safety and efficacy of switching to B/F/TAF among Black adults. In the Phase 3 BRAAVE 2020 study, adults with HIV…